5-HT2C Receptor modulators:: Progress in development of new CNS medicines

被引：14

作者：

Fitzgerald, LW ^{[1
]}

Ennis, MD

机构：

[1] Pharmacia Corp, Struct Analyt & Med Chem, Kalamazoo, MI 49007 USA

[2] Pharmacia Corp, CNS Discovery Res, Kalamazoo, MI 49007 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 | 2002年 / 37卷

关键词：

D O I：

10.1016/S0065-7743(02)37004-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：21 / 30

页数：10

共 87 条

[1]

ADAMS DR, 2000, Patent No. 0012510

[2]

ADAMS DR, 2000, Patent No. 0012481

[3]

ADAMS DR, 2000, Patent No. 0012475

[4]

ADAMS DR, 2000, Patent No. 0012482

[5]

ADAMS DR, 2000, Patent No. 0012502

[6]

ADAMS DR, 2000, Patent No. 0044753

[7] Global increases in seizure susceptibility in mice lacking 5-HT2C receptors:: A behavioral analysis [J].

Applegate, CD ;

Tecott, LH .

EXPERIMENTAL NEUROLOGY, 1998, 154 (02) :522-530

[8] Deletion of the serotonin 5-HT2C receptor PDZ recognition motif prevents receptor phosphorylation and delays resensitization of receptor responses [J].

Backstrom, JR ;

Price, RD ;

Reasoner, DT ;

Sanders-Bush, E .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23620-23626

[9] A review of central 5-HT receptors and their function [J].

Barnes, NM ;

Sharp, T .

NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152

[10] Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1 [J].

Bécamel, C ;

Figge, A ;

Poliak, S ;

Dumuis, A ;

Peles, E ;

Bockaert, J ;

Lübbert, H ;

Ullmer, C .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12974-12982

← 1 2 3 4 5 6 7 8 9 →